{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:17:40Z","timestamp":1785543460285,"version":"3.56.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.pathol.2019.09.007","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T21:57:50Z","timestamp":1573077470000},"page":"100-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["ALCL by any other name: the many facets of anaplastic large cell lymphoma"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3399-2344","authenticated-orcid":false,"given":"Lina","family":"Irshaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.09.007_bib1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.bloodjournal664848","article-title":"The expression of the Hodgkin\u2019s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.007_bib2","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.007_bib3","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.007_bib4","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.007_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.critrevonc.2012.02.005","article-title":"Anaplastic large cell lymphoma, ALK-positive","volume":"83","author":"Ferreri","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.pathol.2019.09.007_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/PAP.0000000000000047","article-title":"Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous","volume":"22","author":"Xing","year":"2015","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5858\/2010-0507-RAR.1","article-title":"Anaplastic large cell lymphoma: twenty-five years of discovery","volume":"135","author":"Kinney","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2019.09.007_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","article-title":"The biology and management of systemic anaplastic large cell lymphoma","volume":"126","author":"Hapgood","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.007_bib9","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2018.213512","article-title":"ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients","author":"Sibon","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.007_bib10","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.007_bib11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.leukres.2009.07.034","article-title":"ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as \u201cleukemic phase\u201d","volume":"34","author":"Lu","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.pathol.2019.09.007_bib12","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.3324\/haematol.2018.215103","article-title":"Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib","volume":"104","author":"Graetz","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.007_bib13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9440(10)61724-5","article-title":"Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplstic large cell lymphoma of T\/null-cell lineage","volume":"159","author":"Rassidakis","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib14","doi-asserted-by":"crossref","first-page":"20852","DOI":"10.1073\/pnas.0810958105","article-title":"Oncogenic kinase NPM\/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)","volume":"105","author":"Marzec","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2019.09.007_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cellsig.2006.09.007","article-title":"The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms","volume":"19","author":"Turner","year":"2007","journal-title":"Cell Signal"},{"issue":"8","key":"10.1016\/j.pathol.2019.09.007_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081074","article-title":"The transcriptional roles of ALK fusion proteins in tumorigenesis","volume":"11","author":"Ducray","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pathol.2019.09.007_bib17","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/bjh.13265","article-title":"Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas","volume":"18","author":"Boi","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.007_bib18","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"129","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.007_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib20","doi-asserted-by":"crossref","first-page":"18525","DOI":"10.18632\/oncotarget.14503","article-title":"The heterogeneous landscape of ALK negative ALCL","volume":"8","author":"Mereu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2019.09.007_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/modpathol.2010.4","article-title":"PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus","volume":"23","author":"Feldman","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.humpath.2017.01.003","article-title":"Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping","volume":"64","author":"Wang","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/COC.0b013e3182185aa2","article-title":"Primary cutaneous anaplastic large-cell lymphoma","volume":"36","author":"Perry","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"10.1016\/j.pathol.2019.09.007_bib24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archdermatol.2009.74","article-title":"Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome","volume":"145","author":"Woo","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pathol.2019.09.007_bib25","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653.012k23_3653_3661","article-title":"Primary and secondary cutaneous CD30+ lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.007_bib26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2133.2003.05248.x","article-title":"Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature","volume":"148","author":"Burg","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pathol.2019.09.007_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2559.2001.01271.x","article-title":"Histological and immunohistochemical characterization of extranodal diffuse large-cell lymphomas with prominent spindle cell features","volume":"39","author":"Wang","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.007_bib28","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1097\/DAD.0b013e31824fec43","article-title":"Cutaneous intravascular anaplastic large T-cell lymphoma: a case report and review of the literature","volume":"34","author":"Iacobelli","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/cup.12047","article-title":"Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases","volume":"40","author":"Plaza","year":"2013","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib30","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","article-title":"Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"132","author":"Luchtel","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.007_bib31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1034\/j.1600-0560.2000.027008392.x","article-title":"Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases","volume":"27","author":"Natkunam","year":"2000","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.2012.065664","article-title":"ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study","volume":"98","author":"Oschlies","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.007_bib33","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.007_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10428194.2015.1064530","article-title":"Genetics of anaplastic large cell lymphoma","volume":"57","author":"Zeng","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.007_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2016-02-694455","article-title":"No TP63 rearrangements in a selected group of primary cutaneous CD30+ lymphoproliferative disorders with aggressive clinical course","volume":"128","author":"Schrader","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.007_bib36","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/bjh.15860","article-title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma","volume":"186","author":"Hapgood","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.007_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/his.12251","article-title":"Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward\u2013report on the lymphoma workshop of the XVI the meeting of the European Association for Hematopathology and the Society for Hematopathology","volume":"64","author":"Attygalle","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.007_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.path.2014.02.001","article-title":"Cutaneous CD30-positive lymphoproliferative disorders","volume":"2","author":"Kempf","year":"2014","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.pathol.2019.09.007_bib39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.humpath.2014.12.008","article-title":"Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin","volume":"46","author":"de la Garza Bravo","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients","volume":"32","author":"Miranda","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.007_bib41","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jamasurg.2017.4026","article-title":"Breast implant-associated anaplastic large cell lymphoma: a systematic review","volume":"152","author":"Leberfinger","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.pathol.2019.09.007_bib42","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1182\/blood-2018-03-785972","article-title":"How I treat breast implant-associated anaplastic large cell lymphoma","volume":"132","author":"Mehta-Shah","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.007_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/PRS.0000000000005568","article-title":"Characteristics and treatment of advanced breast implant-associated anaplastic large cell lymphoma","volume":"143","author":"Collins","year":"2019","journal-title":"Plast Reconstruct Surg"},{"key":"10.1016\/j.pathol.2019.09.007_bib44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.007_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41379-018-0134-3","article-title":"Breast implant-associated anaplastic large cell lymphoma: a review","volume":"32","author":"Quesada","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41379-019-0337-2","article-title":"A\u00a0proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma","author":"Lyapichev","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.humpath.2019.05.007","article-title":"Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas","volume":"90","author":"Tabanelli","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/PRS.0000000000005570","article-title":"Molecular drivers of breast implant-associated anaplastic large cell lymphoma","volume":"143","author":"Blombery","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.pathol.2019.09.007_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.semdp.2016.11.005","article-title":"A\u00a0new era for cutaneous CD30-positive T-cell lymphoproliferative disorders","volume":"34","author":"Kempf","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib50","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/MCB.17.4.2312","article-title":"Role of the nucleophosmin (NPM) portion of the the non-Hodgkin\u2019s lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis","volume":"17","author":"Bischof","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pathol.2019.09.007_bib51","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/gcc.10033","article-title":"Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor","volume":"34","author":"Cools","year":"2002","journal-title":"Genes Chromosom Cancer"},{"key":"10.1016\/j.pathol.2019.09.007_bib52","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0002-9440(10)64945-0","article-title":"A\u00a0novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosoal inversion, inv(2)(p23q35)","volume":"156","author":"Colleoni","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib53","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1182\/blood.V94.9.3265","article-title":"TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations","volume":"94","author":"Hernandez","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.007_bib54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9440(10)64550-6","article-title":"TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors","volume":"157","author":"Lawrence","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2019.09.007_bib55","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/gcc.22104","article-title":"Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma","volume":"52","author":"Feldman","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2019.09.007_bib56","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/gcc.10232","article-title":"Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma","volume":"37","author":"Lamant","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2019.09.007_bib57","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/labinvest.3780249","article-title":"Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma","volume":"81","author":"Tort","year":"2001","journal-title":"Lab Invest"},{"key":"10.1016\/j.pathol.2019.09.007_bib58","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/leu.2016.331","article-title":"Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex","volume":"31","author":"Palacios","year":"2017","journal-title":"Leukemia"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519303976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519303976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T21:07:12Z","timestamp":1664831232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302519303976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0031302519303976"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.007","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALCL by any other name: the many facets of anaplastic large cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}